Since at least seven of the panel's 14 members have ties to the peptide industry or clinics promoting them, it's expected they'll advise removing the restrictionseven though FDA scientists in June recommended against doing so, citing insufficient evidence on the peptides' effectiveness and safety
May 2014;44(5):480-8
FDA also issued a series of letters regarding mostly peptides being sold as research use only (RUO) where the advertising indicated the product was intended for human use
FDA Approval Update | #FDA Advisory Committee Recommends Changing Restrictions on Several Research #Peptides An FDA advisory committee has voted to recommend allowing several peptides, including BPC-157, TB-500, KPV, and MOTS-c to be compounded by licensed pharmacies
Additionally, a 2020 mm specimen was extracted from the non-damaged tissue of the upper back for the purpose of weight determination at days 1, 2, and 3 following euthanization
How does BPC-157 work in the body